LY86 and cardiovascular disorder: Furthermore, loss of MD1 was associated with several cardiovascular diseases; it aggravates maladaptive left atrial fibrosis, ischemia/reperfusion injury, ischemia/reperfusion-related arrhythmia, and inflammation through enhanced activation of the TLR4 signaling pathway (28–31).